Why is Nectar Lifesci. falling/rising?

As of 16-Sep, Nectar Lifescience Ltd's stock price is currently at 17.34, reflecting an increase of 0.8 or 4.84%. The stock has shown a strong performance recently, gaining 23.24% over the past week and outperforming its sector by 4.56%. Despite this positive short-term momentum, the stock has experienced significant declines over longer periods, with a year-to-date drop of 55.54% and a one-year decline of 64.53%. Additionally, while the stock is currently trading above its 5-day, 20-day, and 50-day moving averages, it remains below its 100-day and 200-day moving averages. Notably, there has been a decline in investor participation, with delivery volume falling by 55.5% against the 5-day average, indicating a potential concern regarding sustained interest in the stock. In the broader market context, Nectar Lifescience's recent short-term performance contrasts sharply with the benchmark, as the Sensex has only increased by 1.58% over the same week. This significant outperformance highlights a temporary rebound for the stock amidst a challenging longer-term trend, where it has underperformed the benchmark over one year and three years. The liquidity of the stock remains adequate for trading, with a trading value that supports a small trade size, but the falling delivery volume could suggest caution among investors. Overall, while the stock is currently rising, the long-term performance and declining investor participation may pose challenges for its future trajectory.